Literature DB >> 22477445

A viewpoint on statin effects − benefits and problems.

Thomas F Whayne1.   

Abstract

Year:  2008        PMID： 22477445      PMCID： PMC2728916          DOI： 10.1055/s-0031-1278305

Source DB:  PubMed          Journal:  Int J Angiol        ISSN： 1061-1711


× No keyword cloud information.
  26 in total

1.  Nonprescription statins: not ready for prime time.

Authors:  Thomas F Whayne
Journal:  Am J Cardiol       Date:  2008-03-01       Impact factor: 2.778

Review 2.  Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy.

Authors:  Kumudha Ramasubbu; Jerry Estep; Donna L White; Anita Deswal; Douglas L Mann
Journal:  J Am Coll Cardiol       Date:  2008-01-29       Impact factor: 24.094

3.  Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia.

Authors:  Claude Gagné; Harold E Bays; Stuart R Weiss; Pedro Mata; Katherine Quinto; Michael Melino; Meehyung Cho; Thomas A Musliner; Barry Gumbiner
Journal:  Am J Cardiol       Date:  2002-11-15       Impact factor: 2.778

4.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

5.  A new perspective on nonprescription statins: an opportunity for patient education and involvement.

Authors:  Valentin Fuster
Journal:  Am J Cardiol       Date:  2007-07-10       Impact factor: 2.778

6.  Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

Authors:  John C LaRosa; Scott M Grundy; David D Waters; Charles Shear; Philip Barter; Jean-Charles Fruchart; Antonio M Gotto; Heiner Greten; John J P Kastelein; James Shepherd; Nanette K Wenger
Journal:  N Engl J Med       Date:  2005-03-08       Impact factor: 91.245

7.  Effect of coenzyme q10 on myopathic symptoms in patients treated with statins.

Authors:  Giuseppe Caso; Patricia Kelly; Margaret A McNurlan; William E Lawson
Journal:  Am J Cardiol       Date:  2007-04-03       Impact factor: 2.778

8.  Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany.

Authors:  Wolfgang Koenig; Natalie Khuseyinova; Hannelore Löwel; Gerlinde Trischler; Christa Meisinger
Journal:  Circulation       Date:  2004-09-27       Impact factor: 29.690

9.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Authors:  J R Downs; M Clearfield; S Weis; E Whitney; D R Shapiro; P A Beere; A Langendorfer; E A Stein; W Kruyer; A M Gotto
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.